Kotono Midorikawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kotono Midorikawa has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Emi Kasama
Department of Pharmacology, School of Pharmaceutical Science, Ohu University, 963-8041 Koriyama, Fukushima, Japan
1 shared publication - Fuka Ohnuma
Department of Pharmacology, School of Pharmaceutical Science, Ohu University, 963-8041 Koriyama, Fukushima, Japan
1 shared publication - Haruka Asano
Department of Pharmacology, School of Pharmaceutical Science, Ohu University, 963-8041 Koriyama, Fukushima, Japan
1 shared publication - Kenjiro Seki
Department of Pharmacology, School of Pharmaceutical Science, Ohu University, 963-8041 Koriyama, Fukushima, Japan
1 shared publication - Miho Moriya
Department of Pharmacology, School of Pharmaceutical Science, Ohu University, 963-8041 Koriyama, Fukushima, Japan
1 shared publication - Tohru Matsuki
Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai 480-0392, Japan
1 shared publication
Latest Publications
- Open Access
- 28 September 2025
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 24 (9) , 40000
Time-dependent Potentiation of False Context Fear Memory Through Glucocorticoid Receptor Activation and Mineralocorticoid Receptor Inactivation
Background: Hypothalamic corticotropin-releasing factor (CRF) has been implicated in the formation of false contextual fear memory. Here, we examined the involvement of glucocorticoid (GR) and mineralocorticoid receptors (MR) in this process. Methods: Adult male C57BL/6J mice were exposed to Context B, similar but distinct from Context A, 3 h (B-3 h) after electric foot shock (FS) in Context A, and re-exposed to Context B either 24 h (B-24 h) or 9 days (B-9 d) after FS in Context A. To assess the effect of B-3 h exposure on the specificity of original memory, freezing levels were also measured in Context A (A-24 h or A-9 d) in a separate group, following the B-3 h exposure after FS. GR and MR protein levels in the hippocampal nuclear fractions were analyzed by western blotting. In pharmacological studies, dexamethasone (a GR agonist), fludrocortisone (an MR agonist), and mifepristone (a GR antagonist) were subcutaneously administered to hypothalamic CRF knockdown mice. Results: When mice were exposed to B-3 h after FS, they exhibited increased freezing at B-24 h compared with B-3 h and showed further increases at B-9 d compared with B-24 h, indicating a time-dependent intensification of false contextual fear memory. In contrast, freezing behavior in Context A was reduced at A-24 h and A-9 d after B-3 h exposure compared with mice that were not exposed to B-3 h, suggesting diminished precision of the original memory. Immunoblotting revealed increased nuclear GR levels at B-3 h and decreased MR levels at B-24 h and B-9 d. In CRF knockdown mice, dexamethasone enhanced freezing at B-3 h, whereas fludrocortisone reduced freezing at B-24 h and B-9 d. Co-administration of mifepristone and fludrocortisone suppressed both the formation of false memory at B-3 h and its subsequent enhancement. However, this treatment increased freezing in Context A at A-24 h and A-9 d following B-3 h exposure. Conclusion: Exposure to a similar but distinct context shortly after FS induces false contextual fear memory via GR activation and promotes its time-dependent potentiation through MR inactivation. Such early exposure may also impair the specificity of the original fear memory.
- 28 September 2025
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 24 (9) , 40000
Open AccessTime-dependent Potentiation of False Context Fear Memory Through Glucocorticoid Receptor Activation and Mineralocorticoid Receptor Inactivation
Background: Hypothalamic corticotropin-releasing factor (CRF) has been implicated in the formation of false contextual fear memory. Here, we examined the involvement of glucocorticoid (GR) and mineralocorticoid receptors (MR) in this process. Methods: Adult male C57BL/6J mice were exposed to Context B, similar but distinct from Context A, 3 h (B-3 h) after electric foot shock (FS) in Context A, and re-exposed to Context B either 24 h (B-24 h) or 9 days (B-9 d) after FS in Context A. To assess the effect of B-3 h exposure on the specificity of original memory, freezing levels were also measured in Context A (A-24 h or A-9 d) in a separate group, following the B-3 h exposure after FS. GR and MR protein levels in the hippocampal nuclear fractions were analyzed by western blotting. In pharmacological studies, dexamethasone (a GR agonist), fludrocortisone (an MR agonist), and mifepristone (a GR antagonist) were subcutaneously administered to hypothalamic CRF knockdown mice. Results: When mice were exposed to B-3 h after FS, they exhibited increased freezing at B-24 h compared with B-3 h and showed further increases at B-9 d compared with B-24 h, indicating a time-dependent intensification of false contextual fear memory. In contrast, freezing behavior in Context A was reduced at A-24 h and A-9 d after B-3 h exposure compared with mice that were not exposed to B-3 h, suggesting diminished precision of the original memory. Immunoblotting revealed increased nuclear GR levels at B-3 h and decreased MR levels at B-24 h and B-9 d. In CRF knockdown mice, dexamethasone enhanced freezing at B-3 h, whereas fludrocortisone reduced freezing at B-24 h and B-9 d. Co-administration of mifepristone and fludrocortisone suppressed both the formation of false memory at B-3 h and its subsequent enhancement. However, this treatment increased freezing in Context A at A-24 h and A-9 d following B-3 h exposure. Conclusion: Exposure to a similar but distinct context shortly after FS induces false contextual fear memory via GR activation and promotes its time-dependent potentiation through MR inactivation. Such early exposure may also impair the specificity of the original fear memory.